Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage

por Elshani, Mustafa, Um, In Hwa, Leung, Steve, Reynolds, Paul A., Chapman, Alex, Kudsy, Mary, Harrison, David J.
Publicado 2023

The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial

por Schwenzer, Hagen, De Zan, Erica, Elshani, Mustafa, van Stiphout, Ruud, Kudsy, Mary, Morris, Josephine, Ferrari, Valentina, Um, In Hwa, Chettle, James, Kazmi, Farasat, Campo, Leticia, Easton, Alistair, Nijman, Sebastian, Serpi, Michaela, Symeonides, Stefan, Plummer, Ruth, Harrison, David J., Bond, Gareth, Blagden, Sarah P.
Publicado 2021